# STRYKER CORP (SYK) FY2026 YTD Q2 P&L / Income Statement - Company: STRYKER CORP (SYK) - Period: 2026-01-01 to 2026-06-30 - Filing: Q2 FY2026 10-Q, filed 2026-07-31, accession number 0000310764-26-000050 - Page: https://plicit.ai/financials/syk/fy2026-ytd-q2-income-statement - Chart image: https://plicit.ai/charts/syk-fy2026-ytd-q2-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 12,609,000,000 US dollars - **Cost of sales**: 4,301,000,000 US dollars - **Gross profit**: 8,308,000,000 US dollars - **Total operating expenses**: 5,713,000,000 US dollars - **Operating income**: 2,595,000,000 US dollars - **Other income (expense), net (calculated)**: negative 181,000,000 US dollars - **Earnings before income taxes**: 2,414,000,000 US dollars - **Income taxes**: 393,000,000 US dollars - **Net earnings**: 2,021,000,000 US dollars - **Orthopaedic Instruments**: 1,012,000,000 US dollars - **Other Orthopedics**: 351,000,000 US dollars - **Neuro Cranial Instruments**: 1,287,000,000 US dollars - **Enabling Technologies**: 54,000,000 US dollars - **Undisclosed (calculated)**: 9,905,000,000 US dollars - **Research, development and engineering expenses**: 847,000,000 US dollars - **Selling, general and administrative expenses**: 4,510,000,000 US dollars - **Amortization of intangible assets**: 355,000,000 US dollars - **Asset impairments**: 1,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/syk/fy2026-ytd-q2-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/syk-fy2026-ytd-q2-revenue-by-geography-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 12,609,000,000 US dollars - **Cost of sales**: 4,301,000,000 US dollars - **Gross profit**: 8,308,000,000 US dollars - **Total operating expenses**: 5,713,000,000 US dollars - **Operating income**: 2,595,000,000 US dollars - **Other income (expense), net (calculated)**: negative 181,000,000 US dollars - **Earnings before income taxes**: 2,414,000,000 US dollars - **Income taxes**: 393,000,000 US dollars - **Net earnings**: 2,021,000,000 US dollars - **UNITED STATES**: 9,435,000,000 US dollars - **International**: 3,174,000,000 US dollars - **Research, development and engineering expenses**: 847,000,000 US dollars - **Selling, general and administrative expenses**: 4,510,000,000 US dollars - **Amortization of intangible assets**: 355,000,000 US dollars - **Asset impairments**: 1,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment - Page: https://plicit.ai/financials/syk/fy2026-ytd-q2-income-statement/revenue-by-business-segment - Chart image: https://plicit.ai/charts/syk-fy2026-ytd-q2-revenue-by-business-segment-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 12,609,000,000 US dollars - **Cost of sales**: 4,301,000,000 US dollars - **Gross profit**: 8,308,000,000 US dollars - **Total operating expenses**: 5,713,000,000 US dollars - **Operating income**: 2,595,000,000 US dollars - **Other income (expense), net (calculated)**: negative 181,000,000 US dollars - **Earnings before income taxes**: 2,414,000,000 US dollars - **Income taxes**: 393,000,000 US dollars - **Net earnings**: 2,021,000,000 US dollars - **MedSurg and Neurotechnology**: 6,832,000,000 US dollars - **Orthopaedics**: 5,777,000,000 US dollars - **Research, development and engineering expenses**: 847,000,000 US dollars - **Selling, general and administrative expenses**: 4,510,000,000 US dollars - **Amortization of intangible assets**: 355,000,000 US dollars - **Asset impairments**: 1,000,000 US dollars - **MedSurg and Neurotechnology costs (calculated)**: 5,113,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Orthopaedics costs (calculated)**: 3,923,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 978,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment by Product and Service - Page: https://plicit.ai/financials/syk/fy2026-ytd-q2-income-statement/revenue-by-business-segment-by-product-and-service - Chart image: https://plicit.ai/charts/syk-fy2026-ytd-q2-revenue-by-business-segment-by-product-and-service-sankey.png Income statement for 2026-01-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net sales**: 12,609,000,000 US dollars - **Cost of sales**: 4,301,000,000 US dollars - **Gross profit**: 8,308,000,000 US dollars - **Total operating expenses**: 5,713,000,000 US dollars - **Operating income**: 2,595,000,000 US dollars - **Other income (expense), net (calculated)**: negative 181,000,000 US dollars - **Earnings before income taxes**: 2,414,000,000 US dollars - **Income taxes**: 393,000,000 US dollars - **Net earnings**: 2,021,000,000 US dollars - **MedSurg and Neurotechnology - Endoscopy**: 1,872,000,000 US dollars - **MedSurg and Neurotechnology - Instruments**: 1,923,000,000 US dollars - **MedSurg and Neurotechnology - Medical**: 2,024,000,000 US dollars - **MedSurg and Neurotechnology - Vascular**: 1,013,000,000 US dollars - **Orthopaedics - Hips**: 939,000,000 US dollars - **Orthopaedics - Knees**: 1,363,000,000 US dollars - **Orthopaedics - Ortho Tech**: 1,363,000,000 US dollars - **Orthopaedics - Spinal Implants**: 5,000,000 US dollars - **Orthopaedics - Trauma and Extremities**: 2,107,000,000 US dollars - **Research, development and engineering expenses**: 847,000,000 US dollars - **Selling, general and administrative expenses**: 4,510,000,000 US dollars - **Amortization of intangible assets**: 355,000,000 US dollars - **Asset impairments**: 1,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.